The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Nuclear Medicine Market Expected To Change From 2026 To 2030?
The nuclear medicine market has observed significant expansion in recent years. Its value is projected to rise from $10.18 billion in 2025 to $11.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.9%. This historical growth can be linked to factors such as limited access to nuclear imaging equipment, the high cost of radiopharmaceuticals, a shortage of trained personnel, constrained hospital and diagnostic center infrastructure, and low patient awareness.
The nuclear medicine market is projected to experience substantial expansion in the coming years, with its valuation anticipated to reach $17.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth during the forecast period stems from several factors, including a heightened demand for advanced diagnostic and therapeutic interventions, increased governmental efforts towards cancer and cardiac treatment, greater adoption within hospitals and diagnostic centers, innovations in radiopharmaceuticals and imaging technologies, and a rise in both patient awareness and overall healthcare spending. Key trends identified for this period encompass a wider embrace of diagnostic imaging methods, an expanded application of therapeutic radiopharmaceuticals, a surging requirement for PET and SPECT scans, an intensified concentration on oncology and cardiology uses, and broader deployment in healthcare facilities and diagnostic centers.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp
What Key Drivers Are Fueling The Growth Of The Nuclear Medicine Market?
The expanding regularity and widespread occurrence of cardiovascular disease (CVD) and cancer are anticipated to drive the expansion of the nuclear medicine market in the future. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and blood vessels, while cancer involves the uncontrolled proliferation and dissemination of cells throughout the body. Nuclear cardiac imaging offers a faster diagnosis for heart conditions, and nuclear medicine therapy presents a treatment approach for cancer, potentially employed alongside or following other therapeutic interventions like surgery and chemotherapy. Consequently, the increasing incidence and prevalence of cardiovascular disease and cancer fuel the demand within the nuclear medicine market. For instance, the American Cancer Society Inc., a non-profit health organization based in the US, reported that in January 2023, an estimated 1,958,310 new cancer cases were projected for diagnosis in the US. This figure indicates an increase from over 1,918,030 new cancer cases reported in 2022. Hence, the rising frequency and widespread occurrence of cardiovascular diseases and cancer are key drivers for the nuclear medicine market.
How Are Segments Identified Within The Nuclear Medicine Market Segment Framework?
The nuclear medicine market covered in this report is segmented –
1) By Type: Diagnostic, Therapeutic
2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users
Subsegments:
1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras
2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents
What Trends Are Influencing The Nuclear Medicine Market?
Leading entities within the nuclear medicine sector are prioritizing the creation of novel solutions, including nuclear medicine cyclotrons, to boost the output of radiopharmaceuticals and refine diagnostic imaging potential. These cyclotrons are specialized accelerators of particles designed to generate radioactive isotopes for use in medical imaging and therapy. They achieve this by firing high-energy particles at specific materials, which allows for the creation of radiopharmaceuticals utilized in processes such as positron emission tomography (PET). As an illustration, in January 2024, GE Healthcare China, a medical technology firm based in the US, introduced its initial set of cyclotrons on December 1, 2023, situated at the Chengdu Tianfu International Bio-Town. Such sophisticated particle accelerators play a vital role in nuclear medicine, facilitating the manufacture of medical isotopes applied in molecular imaging and various therapeutic uses. The goal of this endeavor is to construct an all-encompassing nuclear medicine ecosystem, thereby elevating capacities for early detection of diseases and individualized treatment approaches.
Who Are The Companies Competing Within The Nuclear Medicine Market?
Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC
Get The Full Nuclear Medicine Market Report:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
Which Region Is The Top Contributor To The Nuclear Medicine Market By Share?
North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Nuclear Medicine Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
Browse Through More Reports Similar to the Global Nuclear Medicine Market 2026, By The Business Research Company
Inotropic Agents Market Report 2026
https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report
Orthobiologics Market Report
https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report
Spatial Omics Market Report
https://www.thebusinessresearchcompany.com/report/spatial-omics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model